Omeprazole Isomer Data Based On AaiPharma Patents Submitted To FDA
Executive Summary
AaiPharma is submitting data to FDA regarding the isomer content of omeprazole (AstraZeneca's Prilosec) based on patents recently issued to the company.
You may also be interested in...
Sanofi Plavix Patent On Polymorphic Form Covers Currently Marketed Product
Sanofi-Synthelabo's latest patent for its antithrombotic Plavix covers the polymorphic form of clopidogrel that is currently marketed in the U.S., the company said
Sanofi Plavix Patent On Polymorphic Form Covers Currently Marketed Product
Sanofi-Synthelabo's latest patent for its antithrombotic Plavix covers the polymorphic form of clopidogrel that is currently marketed in the U.S., the company said
Prilosec Generics Stability Review By FDA To Be Completed By Mid-November
FDA expects to complete its review of data submitted by AstraZeneca regarding the long-term stability of omeprazole generics in a month.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: